Evolv Reports Strong Q4 Sales, Stock Rises Amid Market Challenges
- Sales Beat Expectations: Evolv reported Q4 sales of $38.5 million, surpassing Wall Street's expectation of $36.44 million with a 32% year-over-year increase, indicating strong market performance despite an adjusted loss of $0.03 per share, laying a solid foundation for future growth.
- Revenue Guidance Raised: The company raised its 2026 revenue target to between $172 million and $178 million, up from the previous $160 million to $165 million, with projected annual recurring revenue (ARR) growth of 20% to 25%, reflecting strong confidence in future growth prospects.
- Contract Extensions Strengthen Market Position: Evolv extended contracts with the NFL's Tennessee Titans and MLB's Houston Astros, with the latter marking the first adoption of its AI weapons detection system in a professional baseball stadium, further solidifying its leadership in sports security.
- Strong Stock Performance: Despite a bearish market in March, Evolv's stock rose 14.2% that month and continued to climb approximately 6.2% in April, demonstrating investor optimism about the company's future, even as broader market uncertainties persist.
Trade with 70% Backtested Accuracy
Analyst Views on EVLV
About EVLV
About the author

- Transaction Overview: Michael Ellenbogen, co-founder of Evolv Technologies, reported the sale of 80,745 shares of Class A Common Stock for approximately $510,000, as per SEC Form 4, indicating ongoing liquidity management within the company.
- Holding Impact: The transaction accounted for 3.73% of Ellenbogen's direct holdings, leaving him with 2,083,961 shares, which demonstrates his strong confidence in the company's future, alongside over one million options still outstanding.
- Market Reaction: The sale was executed under a Rule 10b5-1 plan established on June 12, 2025, indicating that Ellenbogen's actions were independent of short-term market fluctuations, occurring against a backdrop of a 104.39% stock price increase, reflecting his recognition of the company's performance.
- Financial Performance: Evolv reported a revenue of $38.5 million in Q4 2025, a 32% year-over-year increase, and transitioned from a net loss of $15.7 million in Q4 2024 to a net income of $10.9 million, showcasing strong growth potential in the security technology sector.

- Agreement Renewal and Expansion: Evolv Technologies announced the renewal and expansion of its multi-year agreement with Crypto.com Arena, covering the 2024 use of Evolv Express concealed weapons detection systems and adding Evolv eXpedite autonomous bag-screening systems at a designated entrance, aimed at enhancing venue security and efficiency.
- Security System Upgrade: The newly deployed Evolv eXpedite system is expected to optimize entry processes, significantly improving entry efficiency at the Los Angeles venue, which hosts a growing number of sports and live entertainment events, thereby addressing increasing safety demands.
- Market Impact: This agreement expansion not only solidifies Evolv's market position in security technology but may also drive further applications in other large event venues, enhancing the company's competitive edge in the industry.
- Stock Price Reaction: Evolv Technologies' stock rose 0.94% in pre-market trading to $6.4, reflecting positive market sentiment towards the company's expansion of security solutions.

Market Trends: Despite broader market pullbacks, investment funds are actively seeking opportunities in overlooked sectors, particularly in protection and safety equipment, pollution control, and electronics, indicating a shift in focus among retail investors.
Institutional Buying: Institutional algorithms are highlighting urgent demand in specific sectors, with funds prioritizing speed over price, suggesting a strong belief in the potential of these areas despite market volatility.
Emerging Companies: Companies like Axon Enterprises and Sabesp are gaining attention for their innovative approaches in AI-driven public safety and water utility management, respectively, positioning them as key players in their sectors.
Investment Signals: The urgency in institutional buying reflects a strategic move to build positions before broader market trends catch up, indicating a potential for significant returns in the identified sectors.
- Quarterly Performance Beat: Evolv Technologies reported its Q4 results on March 10, with sales of $38.5 million exceeding Wall Street's expectations of $36.44 million, despite an adjusted loss of $0.03 per share, indicating the company's resilience in a challenging market.
- Sustained Revenue Growth: The company achieved an annual recurring revenue (ARR) of $120.5 million, reflecting a 21% year-over-year increase, which underscores significant progress in establishing a stable revenue stream and supports future financial health.
- 2026 Revenue Guidance Raised: Evolv raised its revenue target for 2026 to between $172 million and $178 million from a previous range of $160 million to $165 million, demonstrating management's confidence in future growth despite a bearish market backdrop.
- Contract Extensions Strengthen Market Position: The company extended contracts with the NFL's Tennessee Titans and MLB's Houston Astros, with the latter marking the first adoption of its AI weapons detection system in a professional baseball stadium, further solidifying its leadership in security technology.
- Sales Beat Expectations: Evolv reported Q4 sales of $38.5 million, surpassing Wall Street's expectation of $36.44 million with a 32% year-over-year increase, indicating strong market performance despite an adjusted loss of $0.03 per share, laying a solid foundation for future growth.
- Revenue Guidance Raised: The company raised its 2026 revenue target to between $172 million and $178 million, up from the previous $160 million to $165 million, with projected annual recurring revenue (ARR) growth of 20% to 25%, reflecting strong confidence in future growth prospects.
- Contract Extensions Strengthen Market Position: Evolv extended contracts with the NFL's Tennessee Titans and MLB's Houston Astros, with the latter marking the first adoption of its AI weapons detection system in a professional baseball stadium, further solidifying its leadership in sports security.
- Strong Stock Performance: Despite a bearish market in March, Evolv's stock rose 14.2% that month and continued to climb approximately 6.2% in April, demonstrating investor optimism about the company's future, even as broader market uncertainties persist.
- Contract Expansion: The Houston Astros have signed a multi-year contract extension with Evolv Technology to enhance security at Daikin Park stadium, ensuring effective screening for concealed threats as fans enter.
- Technology Upgrade: The new agreement upgrades the Astros' Express fleet to the latest Evolv Express Gen2 hardware, designed to efficiently screen attendees without causing congestion, thereby improving the overall game-day experience.
- AI Weapons Detection: The agreement also introduces the Evolv eXpedite system, an AI-powered weapons detection solution tailored for entrants carrying multiple items, further bolstering security measures at the venue.
- Market Presence: Evolv Technology is currently deployed at 12 baseball stadiums, including all four sports teams in the Houston area, demonstrating its broad application and market acceptance in the sports security sector.







